![]() Array BioPharma Array BioPharma is focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. | ![]() Amicus Therapeutics Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases. | |
Founding Date | Founding Date 1998 | Founding Date 2002 |
Type | Type Subsidiary | Type Public |
Tags | ||
Locations | Locations Boulder, US HQ Chicago, US Detroit, US Houston, US Miami, US New York, US Phoenix, US | Locations Philadelphia, US HQ Northbridge, AU Pointe Claire, CA Paris, FR München, DE Dublin, IE Milano, IT see more |
Employees | Employees 110 | Employees 58415% increase |
Financial | ||
Revenue (est.) | Revenue (est.) $173.8m (FY, 2018) | Revenue (est.) $528.3m (FY, 2024) |
Cost of goods | Cost of goods $59.4m (FY, 2018) | Cost of goods $52.9m (FY, 2024) |
Gross profit | Gross profit $114.4m (FY, 2018) | Gross profit $475.4m (FY, 2024) |
Net income | Net income ($147.7m) (FY, 2018) | Net income ($56.1m) (FY, 2024) |
Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.
View company